|
|
| | ACETYL COENZYME A (C2:0) LITHIUM Basic information |
| Product Name: | ACETYL COENZYME A (C2:0) LITHIUM | | Synonyms: | ACETYL COENZYME A (C2:0) LITHIUM;Acetyl coenzyme A trilithium salt,Acetyl-S-CoA Li3;Coenzyme A, S-acetate,lithium salt (8CI,9CI);Acetyl-CoA, Acetyl-S-CoA Li3;adenosine, 5'-O-[[[[[(3R)-4-[[3-[[2-(acetylthio)ethyl]amino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl]oxy]hydroxyphosphinyl]oxy]hydroxyphosphinyl]-, 3'-(dihydrogen phosphate), trilithium salt;Acetyl-CoA (lithium salt) | | CAS: | 32140-51-5 | | MF: | C23H39LiN7O17P3S | | MW: | 817.52 | | EINECS: | | | Product Categories: | | | Mol File: | 32140-51-5.mol |  |
| | ACETYL COENZYME A (C2:0) LITHIUM Chemical Properties |
| storage temp. | -20°C | | solubility | H2O: soluble100mg/mL, clear, colorless | | Stability: | Hygroscopic | | InChIKey | FTRFBNATWBKIQU-JHJDYNLLSA-K |
| | ACETYL COENZYME A (C2:0) LITHIUM Usage And Synthesis |
| Uses | Acetyl coenzyme A is suitable in CAT reporter assay for the measurement of chloramphenicol acetyltransferase by incubating the cell extract with 0.1 μCi [14C] chloramphenicol and 0.5mM acetyl-CoA. | | Biochem/physiol Actions | Alterations in the gene encoding acetyl-CoA have been linked to Alzheimer′s disease and mild cognitive impairment. Defects in the gene cause myasthenic syndrome associated with episodic apnea. |
| | ACETYL COENZYME A (C2:0) LITHIUM Preparation Products And Raw materials |
|